Patient characteristics in various heart failure subcategorisations
| HFpEF | HFrEF | HF-VHD | HF-PH | HF-RVSD | χ² | P value | |
| n | 2022 | 1759 | 240 | 289 | 58 | ||
| Age (years) | 81±8 | 78±10 | 81±9 | 78±10 | 79±9 | <0.01 | |
| NT-proBNP | 1780±3111 | 3603±13 450 | 2698±3628 | 2104±2588 | 2309±5051 | <0.01 | |
| Sex (male) | 684 (34%) | 1057 (60%) | 93 (39%) | 128 (44%) | 37 (64%) | 274 | <0.01 |
| IHD | 552 (27%) | 881 (50%) | 54 (23%) | 66 (23%) | 12 (21%) | 265 | <0.01 |
| VHD | 354 (18%) | 398 (23%) | 220 (92%) | 53 (18%) | 17 (29%) | 660 | <0.01 |
| MI | 179 (9%) | 473 (27%) | 21 (9%) | 22 (8%) | 6 (10%) | 257 | <0.01 |
| Obesity | 100 (5%) | 64 (4%) | 11 (5%) | 12 (4%) | 2 (3%) | 4 | 0.39 |
| Hypertension | 1469 (73%) | 1022 (58%) | 141 (59%) | 192 (66%) | 32 (55%) | 96 | <0.01 |
| Diabetes mellitus | 493 (24%) | 381 (22%) | 43 (18%) | 54 (19%) | 11 (19%) | 11 | 0.03 |
| Hypercholesterolaemia | 473 (23%) | 357 (20%) | 28 (12%) | 41 (14%) | 7 (12%) | 31 | <0.01 |
| COPD | 347 (17%) | 309 (18%) | 37 (15%) | 98 (34%) | 15 (26%) | 53 | <0.01 |
| Dementia | 35 (2%) | 33 (2%) | 3 (1%) | 8 (3%) | 0 (0%) | 3 | 0.54 |
| Smoker | 654 (32%) | 519 (30%) | 63 (26%) | 108 (37%) | 14 (24%) | 13 | 0.01 |
| CVA | 277 (14%) | 255 (14%) | 29 (12%) | 30 (10%) | 7 (12%) | 4 | 0.36 |
COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular accident; HF, heart failure; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; IHD, ischaemic heart disease; MI, myocardial infarction; NT-proBNP, N-terminal pro-brain-type natriuretic peptide; PH, pulmonary hypertension; RVSD, right ventricular systolic dysfunction; VHD, valvular heart disease.